Human immunodeficiency virus-positive patient with bilateral corneal endothelial deposits

Optometry

Volumn 77, Issue 10, 2006, Pages 494-498

  Boyer, Stephen P ^a   Gay, Dax A ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Corneal endothelium; Human immunodeficiency virus; Mycobacterium avium complex (MAC); Rifabutin

Indexed keywords

ANTIINFECTIVE AGENT; RIFABUTIN;

AGED; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CORNEA DISEASE; CORNEA ENDOTHELIUM; DIFFERENTIAL DIAGNOSIS; DRUG EFFECT; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; METABOLISM; PATHOLOGY;

AGED; ANTI-BACTERIAL AGENTS; CORNEAL DISEASES; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIUM, CORNEAL; FOLLOW-UP STUDIES; HIV; HIV SEROPOSITIVITY; HUMANS; MALE; RIFABUTIN;

EID: 33748759555     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2006.06.003     Document Type: Article

References (22)

1. Holland G. Acquired immunodeficiency syndrome. In: Fraunfelder F., and Roy F. (Eds). Current ocular therapy (1995), WB Saunders Company, Philadelphia 85-90
2. Martins A.B., Matos E.D., and Lemos A.C. Infection with the Mycobacterium avium complex in patients without predisposing condition-a case report and literature review. Braz J Infect Dis 9 2 (2005) 173-179
3. Holland S.P., Chang C.W., Vagh M., et al. Corneal endothelial deposits in patents with HIV infection or AIDS: epidemiologic evidence of the contribution of rifabutin. Can J Ophthalmol 34 (1999) 204-209
4. Nightingale S.D., Cameron D.W., Gordin F.M., et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 139 (1993) 828-833
5. Kovacs J.A., and Masur H. Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 342 19 (2000) 1416-1429
6. Smith J.A., Mueller B.U., Nussenblatt R.B., et al. Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia. Am J Ophthalmol 129 3 (2000) 164-169
7. Centers for Disease Control. www.cdc.gov/ncidod/dbmd/diseaseinfo/mycobacteriumavium_t.htm. Last accessed October 18, 2005.
8. Aidsmeds. www.aidsmeds.com/NRTIs.htm. Last accessed April 25, 2006.
9. Severin M., and Hartman C. Endothelial alterations in AIDS with CMV. Ophthalmologica 196 (1988) 7-10
10. Brody J.M., Burtrus S.I., Laby D.M., et al. Anterior segment findings in AIDS patients with CMV. Graefes Arch Clin Exp Ophthalmol 233 (1995) 374-376
11. Walter K., Coulter V., Palay D., et al. Corneal endothelial deposits in patients with cytomegalovirus. Am J Ophthalmol 121 (1996) 391-396
12. Mitchell S.M., Barton K., and Lightman S. Corneal endothelial changes in cytomegalovirus retinitis. Eye 8 pt 1 (1994) 41-43
13. Severin M., Hartman C., Schadlich H.J., et al. Endothelial precipitates and cytomegalovirus infection. Fortschr Ophthalmol 86 3 (1989) 227-231
14. Finch C., Chrisman C., Baciewicz A., et al. Rifampin and rifabutin drug interactions. Arch Intern Med 162 9 (2002) 985-992
15. Drugs. www.drugs.com/MTM/rifabutin.html. Last accessed April 21, 2006.
16. Coutinho A.B., Cheema D., Pereira P., et al. Corneal endothelial deposits associated with rifabutin use. J Ocular Pharm Therapeutics 21 (2005) 166-169
17. Saran B.R., Maguire A.M., Nicholos C., et al. Hypopyon uveitis in patients with AIDS treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 112 (1994) 1159-1165
18. Golchin B., and McClellan K. Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteremia. Br J Ophthalmol 87 (2003) 798-799
19. Barlett J., Janus S., and Hiett J. Ocular effects of systemic drugs. Clinical ocular pharmacology (1995), Butterworth-Heinemann, Boston 957-1006
20. Chu D., Zaidman G., Meisler D., et al. Human immunodeficiency virus-positive patients with posterior intracorneal precipitates. Ophthalmology 108 (2001) 1853-1857
21. Centers for Disease Control. HIV/AIDS Surveillance Report, 2003 vol 15 (2004), US Department of Health and Human Services, Atlanta 1-46 CDC
22. Miedziak A.I., Rapuano C.J., and Goldman S. Corneal endothelial precipitates in HIV and CMV. Eye 12 pt 4 (1998) 743-745